Abstract: The disclosure relates to a metal phenolic network (MPN) composition for treating algae in an aqueous environment, in particular to entrap/capture, flocculate, and settle or otherwise remove the algae from a location where it damages the aqueous environment and/or harms organisms in the aqueous environment. The MPN composition includes a metal phenolic network (MPN) film and a secondary flocculant such as a clay material or ionic flocculant. Application of the MPN composition to an aqueous environment, for example a marine environment containing a harmful algal bloom (HAB) induces flocculation of the algae with the MPN composition and sedimentation of the resulting floc. Algae removed from a surface region of the aqueous environment in this way eventually kills the algae at least due to a lack of sunlight, and reduces or eliminates the ability of the algae to further damage the aqueous environment until its eventual death.

Abstract: The disclosure relates to multilayered vesicles, methods for forming multilayered vesicles, and drug delivery complexes including multilayered vesicles. The multilayered vesicles can be formed by adding hydrophobe containing polypeptoid (HCP)-lipid complexes to unilamellar vesicles such as liposomes in an amount effective to form multilayered vesicles. The HCP-lipid complexes can be produced by mixing a hydrophobe containing polypeptoid (HCP) with a first set of unilamellar vesicles. The unilamellar vesicles and/or drug delivery complexes can include various cargoes for delivery, such as water-soluble cargoes, hydrophobic cargoes, etc.

Abstract: Disclosed herein are compositions and methods that allow access to the interior of porous particles by inserting nanotubes into the particles. The compositions and methods disclosed herein are useful in several applications such as in catalytic reactions, plant active delivery, pharmaceutical drug delivery, and in absorbing environmental contaminants.

Abstract: The disclosure relates to a metal phenolic network (MPN) composition for treating algae in an aqueous environment, in particular to entrap/capture, flocculate, and settle or otherwise remove the algae from a location where it damages the aqueous environment and/or harms organisms in the aqueous environment. The MPN composition includes a metal phenolic network (MPN) film and a secondary flocculant such as a clay material or ionic flocculant. Application of the MPN composition to an aqueous environment, for example a marine environment containing a harmful algal bloom (HAB) induces flocculation of the algae with the MPN composition and sedimentation of the resulting floc. Algae removed from a surface region of the aqueous environment in this way eventually kills the algae at least due to a lack of sunlight, and reduces or eliminates the ability of the algae to further damage the aqueous environment until its eventual death.

Abstract: A variety of hydrophobically modified polypeptoids are provided. The hydrophobically modified polypeptoids can include a polyimide backbone having a random copolymer of two or more different types of repeat units, where one or more of the repeat units have nitrogen atom having a hydrophobic substituent attached thereto. Methods of making the hydrophobically modified polypeptoids are also provided, as well as uses of the hydrophobically modified polypeptoids, for example in liposomal drug delivery.

Abstract: The disclosure provides drug delivery devices and methods of making and using the drug delivery devices. The devices include single and multi-layer polymer films made by a breath figure technique having therapeutic agents associated therewith. For example, the devices may be a dual layer polymer film wherein the first layer includes a therapeutic agent incorporated into it by spin coating the first agent with a polymer solution and the second agent is incorporated into the second layer by loading the agent into pores of the second layer after it is spin coated onto the first layer. In some cases one layer provides a burst release and the second layer provides a slow release drug delivery profile. The devices may take on the form of a surgical mesh with a slow release therapeutic drug.

Abstract: The disclosure provides drug delivery devices and methods of making and using the drug delivery devices. The devices include single and multi-layer polymer films made by a breath figure technique having therapeutic agents associated therewith. For example, the devices may be a dual layer polymer film wherein the first layer includes a therapeutic agent incorporated into it by spin coating the first agent with a polymer solution and the second agent is incorporated into the second layer by loading the agent into pores of the second layer after it is spin coated onto the first layer. In some cases one layer provides a burst release and the second layer provides a slow release drug delivery profile. The devices may take on the form of a surgical mesh with a slow release therapeutic drug.

Abstract: The disclosure provides drug delivery devices and methods of making and using the drug delivery devices. The devices include single and multi-layer polymer films made by a breath figure technique having therapeutic agents associated therewith. For example, the devices may be a dual layer polymer film wherein the first layer includes a therapeutic agent incorporated into it by spin coating the first agent with a polymer solution and the second agent is incorporated into the second layer by loading the agent into pores of the second layer after it is spin coated onto the first layer. In some cases one layer provides a burst release and the second layer provides a slow release drug delivery profile. The devices may take on the form of a surgical mesh with a slow release therapeutic drug.

Abstract: The disclosure provides drug delivery devices and methods of making and using the drug delivery devices. The devices include single and multi-layer polymer films made by a breath figure technique having therapeutic agents associated therewith. For example, the devices may be a dual layer polymer film wherein the first layer includes a therapeutic agent incorporated into it by spin coating the first agent with a polymer solution and the second agent is incorporated into the second layer by loading the agent into pores of the second layer after it is spin coated onto the first layer. In some cases one layer provides a burst release and the second layer provides a slow release drug delivery profile. The devices may take on the form of a surgical mesh with a slow release therapeutic drug.

Abstract: A method for cleaning an oil spill in a marine environment includes forming a particle-stabilized emulsion containing seawater, carbon black and at least one oil spill component and allowing the at least one oil spill component to degrade, thereby removing said component from the marine environment. Carbon black can be added to an oil-seawater mixture to form a stabilized emulsion containing at least one oil spill component and the oil spill component allowed to degrade, thereby removing the at least one oil spill component from the oil spill. Also disclosed is an emulsion that includes one or more oil spill components, seawater and carbon black particles.

Abstract: The disclosure provides drug delivery devices and methods of making and using the drug delivery devices. The devices include single and multi-layer polymer films made by a breath figure technique having therapeutic agents associated therewith. For example, the devices may be a dual layer polymer film wherein the first layer includes a therapeutic agent incorporated into it by spin coating the first agent with a polymer solution and the second agent is incorporated into the second layer by loading the agent into pores of the second layer after it is spin coated onto the first layer. In some cases one layer provides a burst release and the second layer provides a slow release drug delivery profile. The devices may take on the form of a surgical mesh with a slow release therapeutic drug.

Abstract: A method for cleaning an oil spill in a marine environment includes forming a particle-stabilized emulsion containing seawater, carbon black and at least one oil spill component and allowing the at least one oil spill component to degrade, thereby removing said component from the marine environment. Carbon black can be added to an oil-seawater mixture to form a stabilized emulsion containing at least one oil spill component and the oil spill component allowed to degrade, thereby removing the at least one oil spill component from the oil spill. Also disclosed is an emulsion that includes one or more oil spill components, seawater and carbon black particles.

Abstract: The present teachings are directed toward hexagonally patterned porous titania synthesized from a titanium isopropoxide precursor using a viscous template of surface-active agents separating nanoscopic bicontinuous channels of water and isooctane. Subsequent catalyst metal salt reduction in the aqueous nanochannels deposits well-separated catalyst metal nanoparticles on the pore surfaces. These nanocomposites exhibit significantly higher carbon monoxide oxidation efficiency than that obtained with known supports with higher specific surface area; efficiency is believed to be due to decreased mass transfer resistance provided the presently disclosed support material.

Abstract: The present teachings are directed toward hexagonally patterned porous titania synthesized from a titanium isopropoxide precursor using a viscous template of surface-active agents separating nanoscopic bicontinuous channels of water and isooctane. Subsequent catalyst metal salt reduction in the aqueous nanochannels deposits well-separated catalyst metal nanoparticles on the pore surfaces. These nanocomposites exhibit significantly higher carbon monoxide oxidation efficiency than that obtained with known supports with higher specific surface area; efficiency is believed to be due to decreased mass transfer resistance provided the presently disclosed support material.

Abstract: A process is described for the enzyme catalyzed synthesis of polymeric microspheres from monomers such as ethylphenol, naphthols and hydroxypyrenes in reverse micelles in the presence of a detergent. Polymeric microspheres synthesized are porous with nonuniform densities. Polymers prepared from naphthols and hydroxypyrenes are fluorescent with electroluminescent properties. A number of materials such as enzymes, drugs and inorganic materials such as iron oxide and cadmium sulfide are encapsulated in the hollow polymeric microspheres synthesized. These encapsulations are carried out during or after the syntheses of the polymeric microspheres. Functional properties of the encapsulated materials such as enzyme, magnetic and nonlinear optical properties are demonstrated in the polymeric composites.

Abstract: A process is disclosed for regulating the size and composition of the internal reaction medium of a membrane mimetic system using clathrate hydrate formation under gas pressure conditions. When the disclosed membrane mimetic system is in contact with a clathrate forming gas, some of the water in the internal reaction medium is converted to crystalline hydrate form, which physically and chemically isolates the water from the remainder of the internal reaction medium. In one preferred process embodiment, the membrane mimetic system is used for enzymatic polymer synthesis in an organized medium to control the size and morphology of the polymer particles formed.